Western Standard LLC’s Keros Therapeutics KROS Stock Holding History

Western Standard LLC’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$34.6M	Buy
2025 Q2	$20.5M	Buy
2025 Q1	$1.37M	Buy